1. Chen, Yang, Zhao, Yin, Yang, Xiaojing, Ma, Jun, Liu, Na. 2022. USP44 regulates irradiation-induced DNA double-strand break repair and suppresses tumorigenesis in nasopharyngeal carcinoma. In Nature communications, 13, 501. doi:10.1038/s41467-022-28158-2. https://pubmed.ncbi.nlm.nih.gov/35079021/
2. Ekstrom, Thomas L, Hussain, Sajjad, Bedekovics, Tibor, Johnsen, Steven A, Galardy, Paul J. . USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming. In Molecular cancer research : MCR, 22, 812-825. doi:10.1158/1541-7786.MCR-23-0454. https://pubmed.ncbi.nlm.nih.gov/38775808/
3. Chen, Sisi, Zhou, Binghai, Huang, Wei, Wang, Wei, Xie, Peiyi. 2023. The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression. In Cell death & disease, 14, 830. doi:10.1038/s41419-023-06358-y. https://pubmed.ncbi.nlm.nih.gov/38097536/
4. Lan, Xianjiang, Atanassov, Boyko S, Li, Wenqian, Workman, Jerry L, Dent, Sharon Y R. . USP44 Is an Integral Component of N-CoR that Contributes to Gene Repression by Deubiquitinating Histone H2B. In Cell reports, 17, 2382-2393. doi:10.1016/j.celrep.2016.10.076. https://pubmed.ncbi.nlm.nih.gov/27880911/
5. Liu, Yan, Yuan, Mengmeng, Xu, Xinxin, Yu, Wei, Ji, Meiju. 2024. USP44 inactivation accelerates the progression of thyroid cancer by inducing ubiquitylation and degradation of p21. In International journal of biological sciences, 20, 5223-5238. doi:10.7150/ijbs.99817. https://pubmed.ncbi.nlm.nih.gov/39430240/